Inventor · disambiguated record
Tong-Ming Fu
Also filed as: FU TONG-MING
6 granted patents·15 pending applications·973 citations·filing 2000–2024
83Inventor score
Files withFU TONG-MING3MERCK SHARP & DOHME3MERCK & CO INC2MERCK SHARP & DOHME LLC2SANOFI PASTEUR INC2
Top patents by PatentIndex Score
21 records- 0192US11638754B2HPV vaccineMERCK SHARP & DOHME·Filed 2021·Granted May 2, 2023·2 cites·24 claims
- 0292US8168757B2PD-1 binding proteinsFINNEFROCK ADAM C·Filed 2009·Granted May 1, 2012·933 cites·19 claims
- 0389US6653125B2Synthetic hepatitis C genesMERCK & CO INC·Filed 2000·Granted Nov 25, 2003·31 cites·3 claims
- 0481US9868777B2CMV neutralizing antigen binding proteinsMERCK SHARP & DOHME·Filed 2014·Granted Jan 16, 2018·4 cites·10 claims
- 0570US2023270850A1Hpv vaccineMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0665US9546355B2Conditional replicating cytomegalovirus as a vaccine for CMVFU TONG-MING·Filed 2012·Granted Jan 17, 2017·3 cites·12 claims
- 0762US2024327847A1Compositions and methods for rna affinitySANOFI SA·Filed 2024·Application pending·0 cites
- 0853US2023048144A1Hpv vaccineMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 0952US2024269270A1Covid-19 vaccines with tocopherol-containing squalene emulsion adjuvantsSANOFI PASTEUR INC·Filed 2021·Application pending·0 cites
- 1052US2005074752A1Synthetic hepatitis C genesMERCK & CO INC·Filed 2003·Application pending·0 cites
- 1151US2006148750A1Polynucleotide vaccines expressing codon optimized HIV-1 Pol and modified HIV-1 PolSHIVER JOHN W·Filed 2006·Application pending·0 cites
- 1250US2024342269A1Optimized nucleotide sequences encoding sars-cov-2 antigensTRANSLATE BIO INC·Filed 2021·Application pending·0 cites
- 1349US2024016918A1Vaccines against sars-cov-2 infectionsSANOFI PASTEUR INC·Filed 2021·Application pending·0 cites
- 1447US2004063653A1Polynucleotide vaccines expressing codon optimized hiv-1 pol and modified hiv-1 polFiled 2000·Application pending·0 cites
- 1547US2003096778A1Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nefFiled 2000·Application pending·0 cites
- 1647US2005215508A1Polynucleotide vaccines expressing codon optimized HIV-1 Nef and modified HIV-1 NefSHIVER JOHN W·Filed 2005·Application pending·0 cites
- 1746US2005106123A1Method of inducing an enhanced immune response against hivFiled 2003·Application pending·0 cites
- 1845US2011136896A1Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereofFU TONG-MING·Filed 2009·Application pending·0 cites
- 1942US2006165664A1Method of inducing an enhanced immune response against hivEMINI EMILIO A·Filed 2003·Application pending·0 cites
- 2040US11230591B2CMV neutralizing antigen binding proteinsMERCK SHARP & DOHME·Filed 2017·Granted Jan 25, 2022·0 cites·17 claims
- 2135US2015307850A1Conditional replicating viral vectorsFU TONG-MING·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →